deltatrials
Terminated PHASE1/PHASE2 NCT00041548

Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation

Sponsor: Mallinckrodt

Conditions Hypoxemia Lung Disease Respiratory Acidosis
Interventions Oxygen nitric oxide for inhalation
Updated 6 times since 2017 Last updated: Oct 18, 2016 Started: May 31, 2002 Primary completion: Jun 30, 2005 Completion: Jun 30, 2005

A PHASE1/PHASE2 clinical study on Hypoxemia and Lung Disease, this trial is terminated or withdrawn. The trial is conducted by Mallinckrodt and has accumulated 6 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE1_PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE1_PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE1_PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE1_PHASE2

    First recorded

May 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mallinckrodt
Data source: Mallinckrodt

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Birmingham, United States